Our immunohistochemistry results aligned with this finding, as poorly differentiated tumor cells exhibited high NR2F6 expression, with a shift from nuclear to cell membrane localization, showing nuclear membrane-positive expression. The gene discussed is NR2F6; the disease is neoplasm.